The United States’ attempt to rebalance the global economy to better serve its interests has resulted in the flight of capital out of the country, harming American businesses and consumers. … READ MORE >
USA
Market Minute: Rising inflation expectations could send yields higher today
The New York Fed’s Survey of Consumer Expectations, to be released on Monday, carries the risk of sending yields higher across the curve. … READ MORE >
Consumer sentiment plunges amid sweeping tariffs
The consumer sentiment index in April fell to its lowest level since 2022, plunging to 50.8 from 57.0 in March. At the same time, inflation expectations rose to their highest levels since the 1980s. … READ MORE >
5 things to know in life sciences: Week of April 7, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
Market Minute: Dollar tumbles as investors exit U.S. assets
A loss of credibility and confidence in the policy to disrupt patterns of trade has spread from domestic financial investors to global fiscal and monetary authorities. … READ MORE >
March inflation moderated in the last clean report before tariffs
Investors and policymakers should anticipate top-line and core inflation to advance at a 4% to 4.5% pace by the middle of the summer. … READ MORE >
Market Minute: Tariffs and the damage done
Even after a surge in equity markets on April 9, American financial conditions stand at 1.1 standard deviations below neutral, indicating a drag on overall growth. … READ MORE >
The potential impact of tariffs on ad spending
The effect of tariffs on consumer spending and the economy as a whole will affect advertising spend from companies that must adjust to the tariffs. … READ MORE >
Capital markets trend roundup: 24-hour trading, diversification, globalization
During the past month, there have been significant development in the capital markets industry as it relates to around-the-clock trading, regulatory reporting, product diversification and further globalization of our financial markets. … READ MORE >
Biopharma IPO outlook: A shift amid uncertainty?
While the biopharma IPO market has been sluggish, there may be a shift in the marketplace later this year, particularly for later-stage biopharma companies. … READ MORE >